Kobayashi R M, Palkovits M, Hruska R E, Rothschild R, Yamamura H I
Brain Res. 1978 Oct 6;154(1):13-23. doi: 10.1016/0006-8993(78)91047-8.
Using the tritiated ligand [3H]quinuclidinyl benzilate ([3H]QNB), a specific muscarinic cholinergic antagonist, the distribution of muscarinic receptors was determined in 75 specific brain regions and nuclei removed by microdissection as well as in large brain areas. [3H]QNB binding was highest in the caudate-putamen; other regions with high binding included the nucleus accumbens, cerebral cortex and hippocampus, certain limbic and thalamic nuclei, superior colliculus, pontine nuclei and the hypoglossal nucleus. Muscarinic cholinergic receptors may be concentrated in these regions. [3H]QNB binding generally correlated well with acetylcholinesterase staining in terminals and is consistent with certain sites as particularly enriched in cholinergic synapses.
利用氚标记配体[3H]东莨菪碱([3H]QNB),一种特异性毒蕈碱型胆碱能拮抗剂,通过显微切割从75个特定脑区和核团以及大脑大区域中去除后,测定了毒蕈碱受体的分布。[3H]QNB结合在尾状核-壳核中最高;其他高结合区域包括伏隔核、大脑皮层和海马体、某些边缘和丘脑核、上丘、脑桥核和舌下神经核。毒蕈碱型胆碱能受体可能集中在这些区域。[3H]QNB结合通常与终末中的乙酰胆碱酯酶染色相关性良好,并且与某些特别富含胆碱能突触的位点一致。